tiprankstipranks
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Australian Market
Want to see AU:NOX full AI Analyst Report?

Noxopharm Ltd. (NOX) Financial Statements

3 Followers

Noxopharm Ltd. Financial Overview

Noxopharm Ltd.'s market cap is currently AU$22.43M. The company's EPS TTM is AU$-0.0153; its P/E ratio is -4.77; Noxopharm Ltd. is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 1.45MAU$ 2.82MAU$ 2.40MAU$ 6.01MAU$ 5.43M
Gross ProfitAU$ 1.45MAU$ -1.45MAU$ -534.81KAU$ 5.86MAU$ 5.17M
Operating IncomeAU$ -3.40MAU$ -9.65MAU$ -7.54MAU$ -16.60MAU$ -15.21M
EBITDAAU$ -3.40MAU$ -5.38MAU$ -5.95MAU$ -20.85MAU$ -23.70M
Net IncomeAU$ -4.46MAU$ -4.88MAU$ -3.58MAU$ -15.06MAU$ -18.67M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 293.57KAU$ 1.55MAU$ 2.32MAU$ 3.01MAU$ 14.01M
Total AssetsAU$ 1.84MAU$ 4.58MAU$ 6.78MAU$ 10.13MAU$ 26.59M
Total DebtAU$ 4.57MAU$ 2.48MAU$ 0.00AU$ 0.00AU$ 160.62K
Net DebtAU$ 4.28MAU$ 924.99KAU$ -2.32MAU$ -3.01MAU$ -13.85M
Total LiabilitiesAU$ 5.48MAU$ 3.89MAU$ 1.29MAU$ 1.06MAU$ 2.48M
Stockholders' EquityAU$ -3.65MAU$ 689.96KAU$ 5.50MAU$ 9.07MAU$ 24.12M
Cash Flow
Free Cash FlowAU$ -2.71MAU$ -5.82MAU$ -684.31KAU$ -10.95MAU$ -13.73M
Operating Cash FlowAU$ -2.71MAU$ -5.82MAU$ -684.31KAU$ -10.95MAU$ -13.73M
Investing Cash FlowAU$ 0.00AU$ 2.48MAU$ 0.00AU$ 123.51KAU$ 0.00
Financing Cash FlowAU$ 1.45MAU$ 2.60MAU$ 0.00AU$ -178.09KAU$ 975.73K
Currency in AUD

Noxopharm Ltd. Earnings and Revenue History

Noxopharm Ltd. Debt to Assets

Noxopharm Ltd. Cash Flow

Noxopharm Ltd. Forecast EPS vs Actual EPS